Company intelligence / Profile preview

CureMatch

San Diego, California, United Statescurematch.com ↗

Ownership: Private
Development stage: Commercial

Overview

The CureMatch platform has demonstrated improved progression-free survival in patients treated with combination therapies based on high matching scores of targeted treatment options. In referenced studies, personalized combination therapy guided by the system led to higher response rates than traditional approaches.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologicImmunotherapyHormone therapy
Industry: Digital Health Medical Devices

Partnerships

UC San Diego Moores Cancer Center

Beyond the preview

Go deeper on CureMatch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CureMatch.

Explore the full profile